350 related articles for article (PubMed ID: 26356837)
1. G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3β Pathway after Ischemia/Reperfusion.
Kabir ME; Singh H; Lu R; Olde B; Leeb-Lundberg LM; Bopassa JC
PLoS One; 2015; 10(9):e0135988. PubMed ID: 26356837
[TBL] [Abstract][Full Text] [Related]
2. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore.
Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG
J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218
[TBL] [Abstract][Full Text] [Related]
4. Activation of G protein-coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardium against ischemia/reperfusion injury by reducing mitochondrial dysfunction and mitophagy.
Feng Y; Madungwe NB; da Cruz Junho CV; Bopassa JC
Br J Pharmacol; 2017 Dec; 174(23):4329-4344. PubMed ID: 28906548
[TBL] [Abstract][Full Text] [Related]
5. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
7. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.
Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z
Eur J Pharmacol; 2009 Feb; 604(1-3):111-6. PubMed ID: 19135050
[TBL] [Abstract][Full Text] [Related]
8. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
Mozaffari MS; Schaffer SW
Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
[TBL] [Abstract][Full Text] [Related]
9. GSK-3β inhibition confers cardioprotection associated with the restoration of mitochondrial function and suppression of endoplasmic reticulum stress in sevoflurane preconditioned rats following ischemia/reperfusion injury.
Wang Y; Ge C; Chen J; Tang K; Liu J
Perfusion; 2018 Nov; 33(8):679-686. PubMed ID: 29987974
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of GSK-3β mediates intralipid-induced cardioprotection against ischemia/reperfusion injury.
Rahman S; Li J; Bopassa JC; Umar S; Iorga A; Partownavid P; Eghbali M
Anesthesiology; 2011 Aug; 115(2):242-53. PubMed ID: 21691195
[TBL] [Abstract][Full Text] [Related]
11. Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening.
Onishi A; Miyamae M; Inoue H; Kaneda K; Okusa C; Inamura Y; Shiomi M; Koshinuma S; Momota Y; Figueredo VM
J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):916-24. PubMed ID: 23266287
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury.
Miura T; Tanno M
Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial PKC-ε deficiency promotes I/R-mediated myocardial injury via GSK3β-dependent mitochondrial permeability transition pore opening.
Wang S; Zhang F; Zhao G; Cheng Y; Wu T; Wu B; Zhang YE
J Cell Mol Med; 2017 Sep; 21(9):2009-2021. PubMed ID: 28266127
[TBL] [Abstract][Full Text] [Related]
15. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
[TBL] [Abstract][Full Text] [Related]
16. Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta.
Chanoit G; Lee S; Xi J; Zhu M; McIntosh RA; Mueller RA; Norfleet EA; Xu Z
Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1227-H1233. PubMed ID: 18660440
[TBL] [Abstract][Full Text] [Related]
17. Consecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioning.
Khaliulin I; Parker JE; Halestrap AP
Cardiovasc Res; 2010 Nov; 88(2):324-33. PubMed ID: 20558443
[TBL] [Abstract][Full Text] [Related]
18. Intralipid protects the heart in late pregnancy against ischemia/reperfusion injury via Caveolin2/STAT3/GSK-3β pathway.
Li J; Ruffenach G; Kararigas G; Cunningham CM; Motayagheni N; Barakai N; Umar S; Regitz-Zagrosek V; Eghbali M
J Mol Cell Cardiol; 2017 Jan; 102():108-116. PubMed ID: 27847332
[TBL] [Abstract][Full Text] [Related]
19. Age-associated differences in activation of Akt/GSK-3beta signaling pathways and inhibition of mitochondrial permeability transition pore opening in the rat heart.
Zhu J; Rebecchi MJ; Tan M; Glass PS; Brink PR; Liu L
J Gerontol A Biol Sci Med Sci; 2010 Jun; 65(6):611-9. PubMed ID: 20427381
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]